These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38792805)

  • 21. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy.
    Qiao W; Sheng S; Li J; Jin R; Hu C
    J Hepatocell Carcinoma; 2024; 11():509-523. PubMed ID: 38468611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.
    Lu Y; Ren S; Jiang J
    BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma.
    Niu XK; He XF
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
    Xin Y; Zhang X; Yang Y; Chen Y; Wang Y; Zhou X; Li X
    J Gastrointest Oncol; 2021 Dec; 12(6):2930-2942. PubMed ID: 35070419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.
    Shuyao W; Mingyang B; Feifei M; Xiaoqin H
    J Gastrointest Surg; 2022 Feb; 26(2):341-351. PubMed ID: 34506016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin.
    Xu L; Zhao D; Tian P; Ding J; Jiang Z; Ni G; Hou Z; Ni C
    J Hepatocell Carcinoma; 2023; 10():2239-2250. PubMed ID: 38107543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.
    Jiang J; Hu H; Liu R; Wang JH; Long XR; Fan J; Yan ZP
    Medicine (Baltimore); 2017 Aug; 96(32):e7390. PubMed ID: 28796032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.
    Zheng Z; Guan R; Zou Y; Jian Z; Lin Y; Guo R; Jin H
    J Inflamm Res; 2022; 15():5089-5102. PubMed ID: 36091335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
    Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
    J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization.
    Tu X; Zhang J; Li M; Lu F; Wang T; Gong W; Xiang B
    J Hepatocell Carcinoma; 2023; 10():1881-1895. PubMed ID: 37901717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 35. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel prognostic nomogram for hepatocellular carcinoma after thermal ablation.
    Tao Q; Zeng Q; Liu W; Liu J; Jiang L; Tu X; Li K; Zhao P; Tang X; Liu Z; Wang L; Xu Q; Zheng Y
    Am J Cancer Res; 2021; 11(10):5126-5140. PubMed ID: 34765316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
    Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.
    Bai S; Yang P; Wei Y; Wang J; Lu C; Xia Y; Si A; Zhang B; Shen F; Tan Y; Wang K
    Front Oncol; 2023; 13():1166327. PubMed ID: 37152055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.